Compare CLPS & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLPS | NMTC |
|---|---|---|
| Founded | 2005 | 2009 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.8M | 31.5M |
| IPO Year | 2018 | N/A |
| Metric | CLPS | NMTC |
|---|---|---|
| Price | $0.93 | $0.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $2.23 |
| AVG Volume (30 Days) | 26.3K | ★ 147.1K |
| Earning Date | 10-17-2025 | 12-16-2025 |
| Dividend Yield | ★ 14.21% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $164,481,414.00 | $6,629,051.00 |
| Revenue This Year | N/A | $162.84 |
| Revenue Next Year | N/A | $26.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 15.17 | ★ 69.00 |
| 52 Week Low | $0.82 | $0.40 |
| 52 Week High | $1.88 | $1.39 |
| Indicator | CLPS | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 49.98 | 43.62 |
| Support Level | $0.90 | $0.63 |
| Resistance Level | $0.98 | $0.73 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 46.94 | 50.09 |
CLPS Inc. is an IT consulting and solutions provider serving international clients in the banking, wealth management, e-commerce, and automotive sectors. The company drives digital transformation using AI, cloud computing, and big data, offering IT consulting, customized solutions, virtual banking training, recruitment, professional training, and software services. It operates mainly in two segments: IT services, which generate the majority of its revenue, and academic education services. The company has a presence in Hong Kong, Singapore, Mainland China, India, Malaysia, and Japan, with the majority of its revenue coming from Mainland China.
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.